Skip to main content
. 2019 Jun 14;33(7):e22948. doi: 10.1002/jcla.22948

Table 1.

Assessment of the precision and accuracy of assay methods that used either patient cerebrospinal fluid as a control for NFL or commercial controls for pNFH

Methods Mean SD CV (%) (95% CI) CVd a (%) Bias (%)
NFL (ng·L−1) 305.3 19.25 6.31 (4.26‐9.32) <9.0
pNFH–level 1 (ng·L−1) 273.9 23.03 8.41 (5.91‐12.16) 6.6 −8.69
pNFH–level 2 (ng·L−1) 1051.1 70.03 6.66 (5.36‐8.31) 4.4 16.79
a

The declared value from the manufacturer.